Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Creatine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Iovate Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Resistance-band Training and Creatine Supplementation Strategies in Healthy Older Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 23, 2024
Lead Product(s) : Creatine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Iovate Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Creatine
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Iovate Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Creatine Supplementation in Young Healthy Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 20, 2024
Lead Product(s) : Creatine
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Iovate Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Creatine
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
February 10, 2014
Lead Product(s) : Creatine
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Creatine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : AlzChem AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Creatine on Bone Mass in Postmenopausal Women
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
November 16, 2011
Lead Product(s) : Creatine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : AlzChem AG
Deal Size : Inapplicable
Deal Type : Inapplicable